|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Loss for the year | |||||
| Adjusted for | |||||
| Accretion | |||||
| Accretion of provision for closure and reclamation | |||||
| Change in fair value of convertible debenture | |||||
| Change in fair value of Gold Stream derivative liability | |||||
| Deferred tax expense | |||||
| Depreciation | |||||
| Exploration and evaluation expenses capitalized in exploration and evaluation assets | |||||
| Finance Fee | |||||
| Flow-through share premium recovery | |||||
| Income tax recovery | |||||
| Gain on sale of exploration and evaluation assets | |||||
| Interest and finance fee expense | |||||
| Write-down of capital assets | |||||
| Unrealized foreign exchange gain | |||||
| Write-down of property plant and equipment | |||||
| Other | |||||
| Changes in non-cash operating working capital | |||||
| Receivables | |||||
| Prepaid expenses | |||||
| Other | |||||
| Accounts payable and accrued liabilities | |||||
| Net cash used in operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchase of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Deposits paid | |||||
| Construction prepayments and deposits paid | |||||
| Exploration and evaluation asset expenditures | |||||
| Net proceeds from sale of net smelter return royalty | |||||
| Additions to mineral property, plant and equipment | |||||
| Sublease payments received | |||||
| Settlement of other liabilities arising from mineral property acquisitions | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Receipt of leasehold incentive | |||||
| Lease payments | |||||
| Repayment of convertible debenture | |||||
| Proceeds from Gold Stream | |||||
| Proceeds from Gold Stream derivative liability | |||||
| Availability fees on Senior Secured Term Loan | |||||
| Finance fee | |||||
| Proceeds from bought deal financing | |||||
| Proceeds from private placements | |||||
| Proceeds from issuance of convertible debenture | |||||
| Proceeds from option exercises | |||||
| Proceeds from warrant exercises | |||||
| Share issue costs | |||||
| Other | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rates on cash and cash equivalents | |||||
| Change in cash and cash equivalents during the year | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Cash and cash equivalents are comprised of: | |||||
| Cash | |||||
| Cash equivalents | |||||
| Interest and finance fee expense in exploration and evaluation expense | |||||
| Loss (gain) on marketable securities | |||||
| Share-based payments | |||||
Loading...